BALCAO · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · SMALL CAP
Cardiff Lexington Corporation CDIX
19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$11.5M
▲ 39.5% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
-1%
ROE · FY25
-5111.3%
Net margin · FY25
-47.7%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 11.5M
Revenue, FY2025 · full 19-year series below
Revenue
Net income
The company lost 48 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-5111.3%
Return on equity, FY2025
ROE
Operating margin9.5%
Net margin-47.7%
Return on assets-20.8%
Each USD of equity lost 5111 cents this year.
Returned to shareholders
USD 50,000.00
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 50,000.00
Net buybacks—
Share of profit-0.9%
Consecutive raises—
USD 50,000.00 in dividends went back to shareholders in a year without profit.
Growth
+27.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+2.6%
+27.3%
+23.6%
+93.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 29.1M
total assets, end of FY2025
Total assetsUSD 29.1M
EquityUSD -2.5M
CashUSD 318,535.00
Gross debtUSD 18.6M
Net debtUSD 18.2M
Current ratio0.87×
Net debt stands at -739% of equity.
History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
Operating income $B
0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
·
·
·
EBITDA $B
0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
·
·
·
Income tax $B
0.0
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
·
·
·
·
−0.01
·
·
−10.41
−126.20
−0.17
−0.52
−11.39
−582.78
0.01
−0.05
−0.04
·
·
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
−1
−3
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−5111.3
−193.4
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Shares out B
0.01
0.01
0.00
0.00
0.17
0.01
0.00
0.00
0.00
0.03
0.01
0.00
0.00
0.12
0.05
0.06
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
57 of 57
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed